Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 18, 2016
Sterigenics International LLC and subsidiary Nordion have entered into an agreement as part of REVISS's Solvent Members Voluntary Liquidation to purchase REVISS Services (UK) Limited and its US subsidiary REVISS Services Incorporated. The transaction...
read more
Thursday, November 02, 2017
Sterigenics International has acquired Toxikon Europe N.V., the European division of Toxikon Corporation, a Bedford, Mass.-based preclinical contract research organization.
read more
Sterigenics International LLC, a global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, has announced expansion at their Wiesbaden, Germany location.
read more
Sterigenics announced it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK.
read more
StemoniX announced the opening of its new, state-of-the-art research & development (R&D) facility in La Jolla, CA.
read more
StemExpress is excited to announce that we will be opening our eighth facility with our newest location in Reno, Nevada.
read more
StemExpress now includes distribution partnerships with ATCG Limited, Kim & Friends, BIOTOOLS, Axil Scientific Pte and Custom Science.
read more
Wednesday, January 02, 2019
Stem Cell Medicine has licensed an exosomes based technology for the treatment of neurodegenerative and neuropsychiatric indications, specifically, autism spectrum disorder.
read more
Thursday, August 10, 2017
Stellar Biotechnologies reported financial results for the three and nine months ended June 30, 2017 and provided an update on its business.
read more
Stellar Biotechnologies initiated the second phase of an expansion project at the Port of Hueneme, north of Los Angeles.
read more
Stellar Biotechnologies announced that third-party trial results have demonstrated that the company's KLH manufacturing methods achieve robust viral clearance.
read more
Wednesday, December 09, 2020
Stelis BioSource has started the next phase of its continued investment program after having already invested well over $100m into its facilities in Bangalore, India.
read more
Wednesday, November 18, 2020
Stelis BioSource has started the next phase of its continued investment program.
read more
Wednesday, February 25, 2026
SteinCares and Shilpa Biologicals announced a strategic licensing agreement to commercialize a biosimilar across Latin America.
read more
Tuesday, January 05, 2021
Stäubli has announced a new Chief Executive Officer.
read more